Imaging of Coronary Plaques in Participants Treated With Evolocumab
Status:
Completed
Trial end date:
2021-01-21
Target enrollment:
Participant gender:
Summary
To evaluate the effect of evolocumab on fibrous cap thickness (FCT) in participants with
non-ST-elevation acute coronary syndrome (NSTE-ACS) who are taking maximally tolerated statin
therapy.